Skip to main content

Evolv Technology Reports Third Quarter Financial Results

— Company Raises Revenue Outlook for 2025 to $142-$145 Million, up 37%-40% Year-Over-Year —

  • Q3'25 Revenue of $42.9 million, up 57% year-over-year
  • Q3'25 Ending ARR1 of $117.2 million, up 25% year-over-year
  • Q3'25 Net Loss of $(1.8) million, with Net Profit Margin of (4)%
  • Q3'25 Adjusted EBITDA2 of $5.1 million, with Adjusted EBITDA Margin2 of 12%

Evolv Technologies Holdings, Inc (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended September 30, 2025.

“We made meaningful progress across many key measures of the business in the third quarter—including subscribers, revenue, and annual recurring revenue, as well as important indicators of profitability and liquidity,” said John Kedzierski, President and Chief Executive Officer of Evolv Technology. “Through strong new customer acquisition and expanding deployments with existing customers, we continue to deliver real-world impact at scale—screening millions of visitors every day across over 1,000 customers. Looking ahead, we’re encouraged by the growing demand for our solutions and are confident in our ability to close the year with momentum as we advance on our goal of building a high-growth, profitable, and cash-generative business.”

Results for the Third Quarter of 2025

Total revenue for the third quarter of 2025 was $42.9 million, an increase of 57% compared to $27.4 million for the third quarter of 2024. Revenue for the third quarter of 2025 was primarily driven by strong new customer additions and continued expansion of deployments across the existing customer base. Revenue for the period also reflected certain notable items that contributed approximately $7.5 million from the following: (i) approximately $3.0 million of revenue (primarily product revenue) associated with the largest customer order in the Company’s history; (ii) approximately $3.0 million attributable to IP license fees and other revenue associated with the Company’s distribution fulfillment model which is being phased out; and (iii) approximately $1.5 million from short-term rental agreements that concluded in the period. Annual Recurring Revenue (“ARR”)1 was $117.2 million at the end of third quarter of 2025, an increase of 25% compared to $93.7 million at the end of the third quarter of 2024. Net loss for the third quarter of 2025 was $(1.8) million, or $(0.01) per basic and diluted share, compared to $(30.4) million, or $(0.19) per basic and diluted share, in the third quarter of 2024. Adjusted earnings (loss)2 for the third quarter of 2025 was $(3.4) million, or $(0.02) per diluted share, compared to adjusted earnings (loss)2 of $(6.9) million, or $(0.04) per diluted share (as restated), for the third quarter of 2024. Adjusted EBITDA2 for the third quarter of 2025 was $5.1 million compared to $(3.0) million in the third quarter of 2024. As of September 30, 2025, the Company had cash, cash equivalents and marketable securities of $56.2 million.

Results for the First Nine Months of 2025

Total revenue for the nine months ended September 30, 2025 was $107.4 million, an increase of 44% compared to $74.8 million for the nine months ended September 30, 2024. Net loss for the nine months ended September 30, 2025 was $(44.0) million, or $(0.26) per basic and diluted share, compared to $(38.3) million, or $(0.25) per basic and diluted share, in the nine months ended September 30, 2024. Adjusted earnings (loss)2 for the nine months ended September 30, 2025 was $(11.5) million, or $(0.07) per diluted share, compared to adjusted earnings (loss)2 of $(30.8) million, or $(0.20) per diluted share, for the nine months ended September 30, 2024. Adjusted EBITDA2 for the nine months ended September 30, 2025 was $9.3 million compared to $(21.3) million in the nine months ended September 30, 2024.

The following table summarizes the breakdown of recurring and non-recurring revenue3 for each period presented:

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

 

2025

 

 

2024

 

% Change

 

 

2025

 

 

2024

 

% Change

Recurring revenue

$

30,120

 

$

23,764

 

27

%

 

$

82,551

 

$

63,741

 

30

%

Non-recurring revenue

 

12,730

 

 

3,596

 

254

%

 

 

24,850

 

 

11,024

 

125

%

Total revenue

$

42,850

 

$

27,360

 

57

%

 

$

107,401

 

$

74,765

 

44

%

The following table summarizes operating cash flows for each period presented:

 

Nine Months Ended

September 30,

 

 

2025

 

 

 

2024

 

Net loss

$

(44,020

)

 

$

(38,297

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities

 

44,660

 

 

 

15,634

 

Changes in operating assets and liabilities

 

2,458

 

 

 

(11,394

)

Net cash provided by (used in) operating activities

$

3,098

 

 

$

(34,057

)

Company Comments on Outlook for 2025

The Company today commented on its business outlook for 2025. The Company's outlook is based on the current indications for its business, which may change at any time. The Company expects total revenues in 2025 to be between $142 to $145 million, reflecting growth of 37% to 40% compared to 2024. The Company believes that this revenue growth, coupled with a focus on operational efficiency, will drive improved profitability and cash flow. The Company expects to deliver positive full year Adjusted EBITDA1 in 2025 with Adjusted EBITDA1 margins in the high single digits. The Company expects to be cash flow positive in the fourth quarter of 2025.

Estimate

 

Issued August 14, 2025

 

Issued November 13, 2025

Total Revenue (Millions)

 

$132-$135

 

$142-$145

Total Revenue Growth Rate

 

27%-30%

 

37%-40%

Adjusted EBITDA Margin2

 

Mid-Single Digits

 

High Single Digits

Company to Host Live Conference Call and Webcast

The Company’s management team plans to host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss the financial results as well as management’s outlook for the business for both 2025 and 2026. The conference call will be webcast live at http://ir.evolvtechnology.com.

About Evolv Technology

Evolv Technologies Holdings, Inc (NASDAQ: EVLV) is designed to transform human security to make a safer, faster, and better experience for the world’s most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv’s advanced systems have scanned more than three billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) 2024 New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal’s (SBJ) 2024 awards for “Best In Fan Experience Technology” and “Best In Sports Technology”. Evolv®, Evolv Express®, Evolv Insights®, Evolv Visual Gun Detection™, Evolv eXpedite™, and Evolv Eva™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit evolv.com.

1 We define Annual Recurring Revenue, or ARR, as subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter normalized to a one-year period. Our calculation of ARR is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases) that may cause any such contract not to be renewed on its existing terms. In addition, the amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to new bookings, cancellations, upgrades, downgrades or other changes in pending renewals, as well as the effects of professional services revenue and acquisitions or divestitures. As a result, ARR should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

2 Non-GAAP Financial Measures In this press release, the Company’s adjusted gross profit (loss), adjusted gross margin, adjusted operating expenses, adjusted operating income (loss), adjusted EBITDA, adjusted EBITDA margin, adjusted earnings (loss), and adjusted earnings per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted gross profit and adjusted gross margin exclude stock-based compensation expense, amortization of capitalized stock-based compensation, non-recurring employee restructuring and other separation costs, and non-recurring inventory charges, which management believes provides a more meaningful representation of contribution margin. Adjusted operating expenses is defined as operating expenses less stock-based compensation expense, loss on impairment of lease equipment, non-recurring employee restructuring and other separation costs, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of on-going operating expense levels. Other non-recurring legal and regulatory costs include non-recurring legal, accounting and professional fees related to the internal investigation, subsequent restatement, certain non-recurring regulatory, litigation and legal matters, as well as fees related to the resolution of the U.S. Federal Trade Commission investigation, net of estimated insurance recoveries. Adjusted operating income (loss), is defined as loss from operations, excluding stock-based compensation expense, amortization of capitalized stock-based compensation, loss on impairment of leased equipment, non-recurring employee restructuring and other separation costs, non-recurring inventory charges, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Adjusted EBITDA and Adjusted EBITDA margin is defined as net income (loss) plus depreciation and amortization, stock-based compensation, interest expense (income), provision for income taxes, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of leased equipment, loss on disposal of leased equipment, non-recurring employee restructuring and other separation costs, non-recurring inventory charges, and other non-recurring legal and regulatory costs. Adjusted earnings (loss) and Adjusted earnings (loss) per diluted share are defined as net income (loss) plus stock-based compensation, amortization of capitalized stock-based compensation, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of leased equipment, non-recurring employee restructuring and other separation costs, non-recurring inventory charges, and other non-recurring legal and regulatory costs. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operating performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures included in this press release. The Company is unable to provide a reconciliation of Adjusted EBITDA to Net Income (Loss) and Adjusted EBITDA Margin to Net Profit Margin, each measure's most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort, because items that impact these GAAP financial measures are not within the Company’s control and/or cannot be reasonably predicted. These items may include, but are not limited to, predicting forward-looking share-based compensation, changes in the fair value of contingent earn out liabilities, changes in the fair value of contingently issuable common stock liabilities and changes in fair value of public warrant liabilities. Such information may have a significant, and potentially unpredictable, impact on the Company’s future financial results.

3 Recurring revenue includes the recurring portion of revenue associated with pure subscription contracts and hardware purchase subscription contracts. Non-recurring revenue includes revenue that is non-recurring in nature, such as product revenue, shipping revenue, and revenue from installation, training, and professional services.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release and related presentation materials other than statements of historical facts, including without limitation statements regarding our strategy, goals, demand for our products, market opportunities, and future financial and operational results. Words such as “believe” “may,” “will,” “expect,” “should,” “could,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “project,” “plan,” “target,” “forecast”, “is/are likely to” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. The forward-looking statements in this press release and related presentation materials are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the amount of insurance reimbursements expected to be received for defense costs for counsel and consultants in connection with the securities litigation and related Securities and Exchange Commission (the “SEC”) and Department of Justice matters, and the following: our history of losses and ability to reach profitability; our reliance on reseller partners; expectations regarding the Company’s strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; the Company’s reliance on third party contract manufacturing and distribution, and a global supply chain; the Company recognizes a substantial portion of its revenue ratably over the term of its agreements, and, as a result, downturns or upturns in sales may not be immediately reflected in its operating results; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the failure of our products to detect threats could result in injury or loss of life, which could harm our brand, reputation, and results of operations; the loss of designation of our Evolv Express® system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; risks related to our business model, which is predicated, in part, on building a customer base that will generate a recurring stream of revenues through the sale of our subscription contracts; the ability for the Company to obtain, maintain, protect and enforce the Company’s intellectual property rights and use of “open source” software; the concentration of the Company’s revenues on a single solution; the Company’s ability to timely design, produce and launch its solutions, the Company’s ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company’s securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risks related to material weaknesses in our internal control over financial reporting and our remediation plans; risks related to increasing attention to and evolving expectations for, environmental, social, and governance initiatives; the impact of fluctuating general economic and market conditions and reductions in spending; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; and litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources. These and other important factors discussed in our most recent report on From 10-Q or 10-K filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. The forward-looking statements in this press release and related presentation materials are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

You should review this press release and the documents that we reference in this press release and related presentation materials with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this press release and related presentation materials, whether as a result of any new information, future events or otherwise.

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except share and per share data)

(Unaudited)

 

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Revenue:

 

 

 

 

 

 

 

Product revenue

$

9,242

 

 

$

1,344

 

 

$

14,092

 

 

$

4,789

 

Subscription revenue

 

22,685

 

 

 

17,909

 

 

 

62,122

 

 

 

47,783

 

Service revenue

 

7,808

 

 

 

6,085

 

 

 

21,224

 

 

 

16,903

 

License fee and other revenue

 

3,115

 

 

 

2,022

 

 

 

9,963

 

 

 

5,290

 

Total revenue

 

42,850

 

 

 

27,360

 

 

 

107,401

 

 

 

74,765

 

Cost of revenue:

 

 

 

 

 

 

 

Cost of product revenue

 

7,960

 

 

 

2,616

 

 

 

16,495

 

 

 

8,569

 

Cost of subscription revenue

 

10,923

 

 

 

7,348

 

 

 

27,713

 

 

 

19,242

 

Cost of service revenue

 

2,338

 

 

 

1,404

 

 

 

5,753

 

 

 

3,749

 

Cost of license fee and other revenue

 

323

 

 

 

183

 

 

 

766

 

 

 

484

 

Total cost of revenue

 

21,544

 

 

 

11,551

 

 

 

50,727

 

 

 

32,044

 

Gross profit

 

21,306

 

 

 

15,809

 

 

 

56,674

 

 

 

42,721

 

Operating expenses:

 

 

 

 

 

 

 

Research and development

 

5,608

 

 

 

5,810

 

 

 

15,207

 

 

 

18,056

 

Sales and marketing

 

11,715

 

 

 

14,966

 

 

 

34,494

 

 

 

47,182

 

General and administrative

 

12,579

 

 

 

13,976

 

 

 

44,789

 

 

 

39,843

 

Restructuring costs

 

 

 

 

 

 

 

2,662

 

 

 

860

 

Loss from impairment of property and equipment

 

 

 

 

209

 

 

 

 

 

 

209

 

Total operating expenses

 

29,902

 

 

 

34,961

 

 

 

97,152

 

 

 

106,150

 

Loss from operations

 

(8,596

)

 

 

(19,152

)

 

 

(40,478

)

 

 

(63,429

)

Other (expense) income, net:

 

 

 

 

 

 

 

Interest expense

 

(713

)

 

 

 

 

 

(714

)

 

 

 

Interest income

 

436

 

 

 

628

 

 

 

1,049

 

 

 

2,394

 

Other income (expense), net

 

(44

)

 

 

34

 

 

 

117

 

 

 

(33

)

Change in fair value of contingent earn-out liability

 

7,521

 

 

 

(8,321

)

 

 

2,297

 

 

 

15,092

 

Change in fair value of contingently issuable/returnable common stock liability/asset

 

2,178

 

 

 

(2,056

)

 

 

(69

)

 

 

2,218

 

Change in fair value of public warrant liability

 

(2,578

)

 

 

(1,576

)

 

 

(6,160

)

 

 

5,461

 

Total other income (expense), net

 

6,800

 

 

 

(11,291

)

 

 

(3,480

)

 

 

25,132

 

Loss before income taxes

 

(1,796

)

 

 

(30,443

)

 

 

(43,958

)

 

 

(38,297

)

Provision for income taxes

 

 

 

 

 

 

$

62

 

 

$

 

Net loss

$

(1,796

)

 

$

(30,443

)

 

$

(44,020

)

 

$

(38,297

)

Net (loss) income attributable to common stockholders – basic and diluted

$

(1,796

)

 

$

(30,443

)

 

$

(44,020

)

 

$

(38,297

)

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – basic and diluted

 

172,790,098

 

 

 

157,709,229

 

 

 

166,327,570

 

 

 

155,760,149

 

Net loss per share - basic and diluted

$

(0.01

)

 

$

(0.19

)

 

$

(0.26

)

 

$

(0.25

)

 

 

 

 

 

 

 

 

Net loss

$

(1,796

)

 

$

(30,443

)

 

$

(44,020

)

 

$

(38,297

)

Other comprehensive income (loss)

 

 

 

 

 

 

 

Cumulative translation adjustment

 

26

 

 

 

(86

)

 

 

(105

)

 

 

(75

)

Total other comprehensive income (loss)

 

26

 

 

 

(86

)

 

 

(105

)

 

 

(75

)

Total comprehensive loss

$

(1,770

)

 

$

(30,529

)

 

$

(44,125

)

 

$

(38,372

)

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)

 

 

September 30, 2025

 

December 31, 2024

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

31,504

 

 

$

37,015

 

Marketable securities

 

24,723

 

 

 

14,927

 

Accounts receivable, net

 

48,883

 

 

 

28,392

 

Inventory

 

8,770

 

 

 

16,963

 

Current portion of contract assets

 

1,212

 

 

 

799

 

Current portion of commission asset

 

5,956

 

 

 

5,429

 

Prepaid expenses and other current assets

 

30,593

 

 

 

17,921

 

Total current assets

 

151,641

 

 

 

121,446

 

Contract assets, noncurrent

 

381

 

 

 

657

 

Commission asset, noncurrent

 

7,759

 

 

 

7,567

 

Property and equipment, net

 

126,919

 

 

 

123,661

 

Operating lease right-of-use assets

 

12,730

 

 

 

13,993

 

Other assets

 

4,859

 

 

 

735

 

Total assets

$

304,289

 

 

$

268,059

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

4,724

 

 

$

10,492

 

Accrued expenses and other current liabilities

 

33,954

 

 

 

19,508

 

Current portion of deferred revenue

 

77,904

 

 

 

64,506

 

Current portion of operating lease liabilities

 

2,765

 

 

 

2,203

 

Total current liabilities

 

119,347

 

 

 

96,709

 

Deferred revenue, noncurrent

 

18,464

 

 

 

20,266

 

Long-term debt, noncurrent

 

28,528

 

 

 

 

Operating lease liabilities, noncurrent

 

11,107

 

 

 

12,326

 

Contingent earn-out liability, noncurrent

 

10,512

 

 

 

12,809

 

Contingently issuable common stock liability, noncurrent

 

3,638

 

 

 

4,001

 

Public warrant liability, noncurrent

 

10,457

 

 

 

4,297

 

Total liabilities

 

202,053

 

 

 

150,408

 

 

 

 

 

Stockholders’ equity:

 

 

 

Preferred stock, $0.0001 par value; 100,000,000 authorized at September 30, 2025 and December 31, 2024; no shares issued and outstanding at September 30, 2025 and December 31, 2024

 

 

 

 

 

Common stock, $0.0001 par value; 1,100,000,000 shares authorized at September 30, 2025 and December 31, 2024; 173,803,265 and 159,602,069 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively

 

17

 

 

 

16

 

Additional paid-in capital

 

501,040

 

 

 

472,331

 

Accumulated other comprehensive loss

 

(137

)

 

 

(32

)

Accumulated deficit

 

(398,684

)

 

 

(354,664

)

Stockholders’ equity

 

102,236

 

 

 

117,651

 

Total liabilities and stockholders’ equity

$

304,289

 

 

$

268,059

 

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

 

Nine Months Ended

September 30,

 

 

2025

 

 

 

2024

 

Cash flows from operating activities:

 

 

 

Net loss

$

(44,020

)

 

$

(38,297

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

Depreciation and amortization

 

17,859

 

 

 

11,933

 

Write-off of inventory and change in inventory reserve

 

2,016

 

 

 

3,151

 

Loss from impairment of property and equipment

 

 

 

 

209

 

Loss on disposal of property and equipment

 

3,503

 

 

 

 

Stock-based compensation

 

15,816

 

 

 

21,364

 

Non-cash interest expense

 

195

 

 

 

 

Amortization of premium on marketable securities, net of change in accrued interest

 

10

 

 

 

261

 

Non-cash lease expense

 

1,263

 

 

 

1,116

 

Change in allowance for expected credit losses

 

66

 

 

 

371

 

Change in fair value of earn-out liability

 

(2,297

)

 

 

(15,092

)

Change in fair value of contingently issuable common stock

 

69

 

 

 

(2,218

)

Change in fair value of public warrant liability

 

6,160

 

 

 

(5,461

)

Changes in operating assets and liabilities

 

 

 

Accounts receivable

 

(20,557

)

 

 

(13,679

)

Inventory

 

11,079

 

 

 

(8,327

)

Commission assets

 

(719

)

 

 

(1,005

)

Contract assets

 

(137

)

 

 

993

 

Other assets

 

437

 

 

 

333

 

Prepaid expenses and other current assets

 

(17,331

)

 

 

(4,093

)

Accounts payable

 

1,845

 

 

 

216

 

Deferred revenue

 

11,596

 

 

 

13,559

 

Accrued expenses and other current liabilities

 

16,902

 

 

 

1,655

 

Operating lease liability

 

(657

)

 

 

(1,046

)

Net cash provided by (used in) operating activities

 

3,098

 

 

 

(34,057

)

Cash flows from investing activities:

 

 

 

Development of internal-use software

 

(4,311

)

 

 

(4,773

)

Purchases of property and equipment

 

(29,109

)

 

 

(24,443

)

Purchases of marketable securities

 

(34,481

)

 

 

(14,567

)

Proceeds from maturities of marketable securities

 

24,675

 

 

 

55,635

 

Net cash (used in) provided by investing activities

 

(43,226

)

 

 

11,852

 

Cash flows from financing activities:

 

 

 

Proceeds from exercise of stock options

 

8,406

 

 

 

1,151

 

Proceeds from long-term debt

 

26,316

 

 

 

 

Net cash provided by financing activities

 

34,722

 

 

 

1,151

 

Effect of exchange rate changes on cash and cash equivalents

 

(105

)

 

 

(75

)

Net decrease in cash, cash equivalents and restricted cash

 

(5,511

)

 

 

(21,129

)

Cash, cash equivalents and restricted cash

 

 

 

Cash, cash equivalents and restricted cash at beginning of period

 

37,015

 

 

 

67,437

 

Cash, cash equivalents and restricted cash at end of period

$

31,504

 

 

$

46,308

 

EVOLV TECHNOLOGY

SUMMARY OF KEY OPERATING STATISTICS

(Unaudited)

 

 

Three Months Ended or as of,

($ in thousands)

 

March 31,

2024

 

June 30,

2024

 

September 30,

2024

 

December 31,

2024

 

March 31,

2025

 

June 30,

2025

 

September 30,

2025

New customers

 

 

53

 

 

84

 

 

52

 

 

60

 

 

54

 

 

63

 

 

62

Annual recurring revenue

 

$

79,192

 

$

87,011

 

$

93,676

 

$

99,351

 

$

105,990

 

$

110,516

 

$

117,200

Recurring revenue

 

$

18,961

 

$

21,016

 

$

23,764

 

$

23,678

 

$

25,753

 

$

26,678

 

$

30,120

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES

(In thousands)

(Unaudited)

 

 

Three Months Ended,

 

 

March 31,

2024

 

June 30,

2024

 

September 30,

2024

 

December 31,

2024

 

March 31,

2025

 

June 30,

2025

 

September 30,

2025

 

 

(Restated)

 

(Restated)

 

 

 

 

 

 

 

 

 

 

Operating expenses, GAAP

 

$

34,061

 

 

$

37,128

 

 

$

34,961

 

 

$

35,619

 

 

$

33,539

 

 

$

33,711

 

 

$

29,902

 

Stock-based compensation

 

 

(6,292

)

 

 

(7,254

)

 

 

(7,263

)

 

 

(3,159

)

 

 

(4,660

)

 

 

(5,265

)

 

 

(5,121

)

Loss on impairment of leased equipment

 

 

 

 

 

 

 

 

(209

)

 

 

(15

)

 

 

 

 

 

 

 

 

 

Non-recurring employee restructuring and other separation costs

 

 

 

 

 

(1,000

)

 

 

 

 

 

(2,060

)

 

 

(2,137

)

 

 

(827

)

 

 

(6

)

Other non-recurring legal and regulatory costs

 

 

(476

)

 

 

(2,185

)

 

 

(2,339

)

 

 

(7,284

)

 

 

(3,561

)

 

 

(5,979

)

 

 

36

 

Adjusted operating expenses

 

$

27,293

 

 

$

26,689

 

 

$

25,150

 

 

$

23,101

 

 

$

23,181

 

 

$

21,640

 

 

$

24,811

 

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED GROSS PROFIT, GAAP GROSS MARGIN TO ADJUSTED GROSS MARGIN AND GAAP INCOME (LOSS) FROM OPERATIONS TO ADJUSTED OPERATING INCOME (LOSS)

(In thousands)

(Unaudited)

 

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Revenue

$

42,850

 

 

$

27,360

 

 

$

107,401

 

 

$

74,765

 

Cost of revenue

 

21,544

 

 

 

11,551

 

 

 

50,727

 

 

 

32,044

 

Gross profit, GAAP

 

21,306

 

 

 

15,809

 

 

 

56,674

 

 

 

42,721

 

Stock-based compensation

 

269

 

 

 

244

 

 

 

770

 

 

 

555

 

Amortization of capitalized stock-based compensation

 

114

 

 

 

23

 

 

 

324

 

 

 

52

 

Non-recurring employee restructuring and other separation costs

 

 

 

 

 

 

 

6

 

 

 

 

Non-recurring inventory charges

 

 

 

 

1,471

 

 

 

 

 

 

2,607

 

Adjusted gross profit*

$

21,689

 

 

$

17,547

 

 

$

57,774

 

 

$

45,935

 

 

 

 

 

 

 

 

 

Gross margin %

 

49.7

%

 

 

57.8

%

 

 

52.8

%

 

 

57.1

%

Adjusted gross margin %

 

50.6

%

 

 

64.1

%

 

 

53.8

%

 

 

61.4

%

 

*Beginning in the three month period ended September 30, 2025, and on a go-forward basis, management has determined that the loss on disposal of leased equipment should no longer be considered a non-recurring expense, and accordingly, loss on disposal of leased equipment is now reflected within non-GAAP gross margins and adjusted loss from operations.

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Loss from operations, GAAP

$

(8,596

)

 

$

(19,152

)

 

$

(40,478

)

 

$

(63,429

)

Stock-based compensation

 

5,390

 

 

 

7,507

 

 

 

15,816

 

 

 

21,364

 

Amortization of capitalized stock-based compensation

 

114

 

 

 

23

 

 

 

324

 

 

 

52

 

Loss on impairment of lease equipment

 

 

 

 

209

 

 

 

 

 

 

209

 

Non-recurring employee restructuring and other separation costs

 

6

 

 

 

 

 

 

2,976

 

 

 

1,000

 

Non-recurring inventory charges

 

 

 

 

1,471

 

 

 

 

 

 

2,607

 

Other non-recurring legal and regulatory costs

 

(36

)

 

 

2,339

 

 

 

9,504

 

 

 

5,000

 

Adjusted loss from operations*

$

(3,122

)

 

$

(7,603

)

 

$

(11,858

)

 

$

(33,197

)

 

*Beginning this quarter, and on a go-forward basis, management has determined that the loss on disposal of leased equipment should no longer be considered a non-recurring expense, and accordingly, loss on disposal of leased equipment is now reflected within non-GAAP gross margins and adjusted loss from operations.

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA AND NET PROFIT MARGIN TO ADJUSTED EBITDA MARGIN

(In thousands)

(Unaudited)

 

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Net loss

$

(1,796

)

 

$

(30,443

)

 

$

(44,020

)

 

$

(38,297

)

Depreciation & amortization

 

6,541

 

 

 

4,575

 

 

 

17,859

 

 

 

11,933

 

Stock-based compensation

 

5,390

 

 

 

7,507

 

 

 

15,816

 

 

 

21,364

 

Interest expense (income)

 

277

 

 

 

(628

)

 

 

(335

)

 

 

(2,394

)

Provision for income taxes

 

 

 

 

 

 

 

62

 

 

 

 

Change in fair value of contingent earn-out liability

 

(7,521

)

 

 

8,321

 

 

 

(2,297

)

 

 

(15,092

)

Change in fair value of contingently issuable/returnable common stock liability/asset

 

(2,178

)

 

 

2,056

 

 

 

69

 

 

 

(2,218

)

Change in fair value of public warrant liability

 

2,578

 

 

 

1,576

 

 

 

6,160

 

 

 

(5,461

)

Loss on impairment of leased equipment

 

 

 

 

209

 

 

 

 

 

 

209

 

Loss on disposal of leased equipment

 

1,870

 

 

 

 

 

 

3,503

 

 

 

 

Non-recurring employee restructuring and other separation costs

 

6

 

 

 

 

 

 

2,976

 

 

 

1,000

 

Non-recurring inventory charges

 

 

 

 

1,471

 

 

 

 

 

 

2,607

 

Other non-recurring legal and regulatory costs

 

(36

)

 

 

2,339

 

 

 

9,504

 

 

 

5,000

 

Adjusted EBITDA

$

5,131

 

 

$

(3,017

)

 

$

9,297

 

 

$

(21,349

)

 

 

 

 

 

 

 

 

Net profit margin %

 

(4.2

)%

 

 

(111.3

)%

 

 

(41.0

)%

 

 

(51.2

)%

Impact of adjustments from Net loss to Adjusted EBITDA

 

16.2

%

 

 

100.3

%

 

 

49.6

%

 

 

22.6

%

Adjusted EBITDA margin %

 

12.0

%

 

 

(11.0

)%

 

 

8.7

%

 

 

(28.6

)%

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EARNINGS (LOSS)

(In thousands, except share and per share data)

(Unaudited)

 

 

Three Months Ended

September 30,

 

Nine Months Ended

September 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Net loss

$

(1,796

)

 

$

(30,443

)

 

$

(44,020

)

 

$

(38,297

)

Stock-based compensation

 

5,390

 

 

 

7,507

 

 

 

15,816

 

 

 

21,364

 

Amortization of capitalized stock-based compensation

 

114

 

 

 

23

 

 

 

324

 

 

 

52

 

Change in fair value of contingent earn-out liability

 

(7,521

)

 

 

8,321

 

 

 

(2,297

)

 

 

(15,092

)

Change in fair value of contingently issuable/returnable common stock liability/asset

 

(2,178

)

 

 

2,056

 

 

 

69

 

 

 

(2,218

)

Change in fair value of public warrant liability

 

2,578

 

 

 

1,576

 

 

 

6,160

 

 

 

(5,461

)

Loss on impairment of lease equipment

 

 

 

 

209

 

 

 

 

 

 

209

 

Non-recurring employee restructuring and other separation costs

 

6

 

 

 

 

 

 

2,976

 

 

 

1,000

 

Non-recurring inventory charges

 

 

 

 

1,471

 

 

 

 

 

 

2,607

 

Other non-recurring legal and regulatory costs

 

(36

)

 

 

2,339

 

 

 

9,504

 

 

 

5,000

 

Adjusted loss

$

(3,443

)

 

$

(6,941

)

 

$

(11,468

)

 

$

(30,836

)

 

 

 

 

 

 

 

 

Weighted average common shares outstanding – diluted

 

172,790,098

 

 

 

157,709,229

 

 

 

166,327,570

 

 

 

155,760,149

 

 

 

 

 

 

 

 

 

Adjusted loss per share – diluted

$

(0.02

)

 

$

(0.04

)

 

$

(0.07

)

 

$

(0.20

)

 

*Stock-based compensation, amortization of capitalized stock-based compensation, and non-recurring restructuring and other employee separation costs were recorded in the condensed consolidated statements of operations and comprehensive loss (income) as follows. Prior period amounts are being shown for comparative purposes:

 

Three Months Ended,

 

March 31,

2024

 

June 30,

2024

 

September 30,

2024

 

December 31,

2024

 

March 31,

2025

 

June 30,

2025

 

September 30,

2025

Stock-based compensation:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of product revenue

$

 

$

5

 

$

4

 

$

8

 

 

$

8

 

$

17

 

$

32

Cost of subscription revenue

 

91

 

 

110

 

 

169

 

 

154

 

 

 

137

 

 

167

 

 

146

Cost of service revenue

 

44

 

 

51

 

 

63

 

 

61

 

 

 

67

 

 

74

 

 

72

Cost of license fee and other revenue

 

3

 

 

7

 

 

8

 

 

10

 

 

 

7

 

 

24

 

 

19

Research and development

 

902

 

 

1,222

 

 

1,243

 

 

1,153

 

 

 

1,115

 

 

1,154

 

 

1,227

Sales and marketing

 

2,959

 

 

2,724

 

 

2,516

 

 

2,747

 

 

 

1,048

 

 

1,710

 

 

1,480

General and administrative

 

2,431

 

 

3,308

 

 

3,504

 

 

(741

)

 

 

1,972

 

 

2,401

 

 

2,414

Restructuring costs

 

 

 

 

 

 

 

 

 

 

525

 

 

 

 

Total stock-based compensation

$

6,430

 

$

7,427

 

$

7,507

 

$

3,392

 

 

$

4,879

 

$

5,547

 

$

5,390

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of capitalized stock-based compensation:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of subscription revenue

$

8

 

$

8

 

$

13

 

$

47

 

 

$

59

 

$

60

 

$

63

Cost of service revenue

 

6

 

 

7

 

 

10

 

 

38

 

 

 

44

 

 

47

 

 

51

Total amortization of capitalized stock-based compensation

$

14

 

$

15

 

$

23

 

$

85

 

 

$

103

 

$

107

 

$

114

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-recurring employee restructuring and other separation costs:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of service revenue

$

 

$

 

$

 

$

 

 

$

 

$

6

 

 

Research and development

 

 

 

 

 

 

 

 

 

 

 

 

31

 

 

Sales and marketing

 

 

 

140

 

 

 

 

63

 

 

 

 

 

613

 

$

6

General and administrative

 

 

 

 

 

 

 

1,997

 

 

 

 

 

183

 

 

Restructuring costs

 

 

 

860

 

 

 

 

 

 

 

2,137

 

 

 

 

Total non-recurring employee restructuring and other separation costs

$

 

$

1,000

 

$

 

$

2,060

 

 

$

2,137

 

$

833

 

$

6

 

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  237.58
-6.62 (-2.71%)
AAPL  272.95
-0.52 (-0.19%)
AMD  247.96
-10.93 (-4.22%)
BAC  52.87
-1.24 (-2.29%)
GOOG  279.12
-8.31 (-2.89%)
META  609.89
+0.88 (0.14%)
MSFT  503.29
-7.85 (-1.54%)
NVDA  186.86
-6.94 (-3.58%)
ORCL  217.57
-9.42 (-4.15%)
TSLA  401.99
-28.61 (-6.64%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.